{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:12:48Z","timestamp":1779243168992,"version":"3.51.4"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Invasive aspergillosis (IA) resulting from infection by Aspergillus fumigatus is a leading cause of death in immunosuppressed populations. There are limited therapeutic options for this disease and currently no vaccine. There is evidence that some anti\u2013A. fumigatus mAbs can provide protection against IA. However, vaccine development has been impeded by a paucity of immunological targets on this organism demonstrated to provide protective responses. Sialylated oligosaccharide epitopes found on a variety of pathogens, including fungi and group B streptococci (GBS), are thought to be major virulence factors of these organisms facilitating pathogen attachment to host cells and modulating complement activation and phagocytosis. Because some of these oligosaccharide structures are conserved across kingdoms, we screened a panel of mAbs raised against GBS serotypes for reactivity to A. fumigatus. This approach revealed that SMB19, a GBSIb type\u2013specific mAb, reacts with A. fumigatus conidia and hyphae. The presence of this Ab in mice, as a result of passive or active immunization, or by enforced expression of the SMB19 H chain as a transgene, results in significant protection in both i.v. and airway-induced models of IA. This study demonstrates that some Abs generated against bacterial polysaccharides engage fungal pathogens and promote their clearance in vivo and thus provide rationale of alternative strategies for the development of vaccines or therapeutic mAbs against these organisms.<\/jats:p>","DOI":"10.4049\/jimmunol.1401940","type":"journal-article","created":{"date-parts":[[2015,3,28]],"date-time":"2015-03-28T14:45:39Z","timestamp":1427553939000},"page":"4387-4396","source":"Crossref","is-referenced-by-count":15,"title":["Antibodies Generated against Streptococci Protect in a Mouse Model of Disseminated Aspergillosis"],"prefix":"10.1093","volume":"194","author":[{"given":"Rebekah E","family":"Wharton","sequence":"first","affiliation":[{"name":"Department of Microbiology, University of Alabama at Birmingham , Birmingham, AL 35294"},{"name":"Department of Pathology, University of Alabama at Birmingham , Birmingham, AL 35294"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily K","family":"Stefanov","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University of Alabama at Birmingham , Birmingham, AL 35294"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R Glenn","family":"King","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University of Alabama at Birmingham , Birmingham, AL 35294"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F","family":"Kearney","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University of Alabama at Birmingham , Birmingham, AL 35294"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,5,1]]},"reference":[{"key":"2025030706145881500_r1","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/EC.00274-07","article-title":"Aspergillus fumigatus: principles of pathogenesis and host defense","volume":"6","author":"Hohl","year":"2007","journal-title":"Eukaryot. Cell"},{"key":"2025030706145881500_r2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1537","article-title":"Advances in combating fungal diseases: vaccines on the threshold","volume":"5","author":"Cutler","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"2025030706145881500_r3","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.4049\/jimmunol.176.3.1712","article-title":"Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism","volume":"176","author":"Montagnoli","year":"2006","journal-title":"J. Immunol."},{"key":"2025030706145881500_r4","doi-asserted-by":"crossref","first-page":"e1002372","DOI":"10.1371\/journal.ppat.1002372","article-title":"Galactosaminogalactan, a new immunosuppressive polysaccharide of Aspergillus fumigatus","volume":"7","author":"Fontaine","year":"2011","journal-title":"PLoS Pathog."},{"key":"2025030706145881500_r5","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1128\/iai.62.12.5424-5433.1994","article-title":"Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus","volume":"62","author":"Latg\u00e9","year":"1994","journal-title":"Infect. Immun."},{"key":"2025030706145881500_r6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/eji.200323790","article-title":"A role for antibodies in the generation of memory antifungal immunity","volume":"33","author":"Montagnoli","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"2025030706145881500_r7","doi-asserted-by":"crossref","first-page":"e5392","DOI":"10.1371\/journal.pone.0005392","article-title":"Protection by anti-\u03b2-glucan antibodies is associated with restricted \u03b2-1,3 glucan binding specificity and inhibition of fungal growth and adherence","volume":"4","author":"Torosantucci","year":"2009","journal-title":"PLoS ONE"},{"key":"2025030706145881500_r8","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/IAI.00278-07","article-title":"An anti-\u03b2-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo","volume":"75","author":"Rachini","year":"2007","journal-title":"Infect. Immun."},{"key":"2025030706145881500_r9","first-page":"1063","article-title":"Monoclonal immunoglobulin G1 directed against Aspergillus fumigatus cell wall glycoprotein protects against experimental murine aspergillosis","volume":"12","author":"Chaturvedi","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"2025030706145881500_r10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vetimm.2008.04.020","article-title":"Immune response to fungal infections","volume":"125","author":"Blanco","year":"2008","journal-title":"Vet. Immunol. Immunopathol."},{"key":"2025030706145881500_r11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1086\/375536","article-title":"Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III","volume":"188","author":"Baker","year":"2003","journal-title":"J. Infect. Dis."},{"key":"2025030706145881500_r12","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.4049\/jimmunol.0902473","article-title":"Generation of B cell memory to the bacterial polysaccharide \u03b1-1,3 dextran","volume":"183","author":"Foote","year":"2009","journal-title":"J. Immunol."},{"key":"2025030706145881500_r13","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1128\/iai.60.4.1598-1602.1992","article-title":"Murine monoclonal antibodies to type Ib polysaccharide of group B streptococci bind to human milk oligosaccharides","volume":"60","author":"Pritchard","year":"1992","journal-title":"Infect. Immun."},{"key":"2025030706145881500_r14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/intimm\/9.1.27","article-title":"Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone","volume":"9","author":"Chen","year":"1997","journal-title":"Int. Immunol."},{"key":"2025030706145881500_r15","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.4049\/jimmunol.1200702","article-title":"Antibodies generated against conserved antigens expressed by bacteria and allergen-bearing fungi suppress airway disease","volume":"189","author":"Kin","year":"2012","journal-title":"J. Immunol."},{"key":"2025030706145881500_r16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/eji.1830111106","article-title":"Monoclonal vs. heterogeneous anti-H-8 antibodies in the analysis of the anti-phosphorylcholine response in BALB\/c mice","volume":"11","author":"Kearney","year":"1981","journal-title":"Eur. J. Immunol."},{"key":"2025030706145881500_r17","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1128\/AAC.45.12.3474-3481.2001","article-title":"Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate","volume":"45","author":"Bowman","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"2025030706145881500_r18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/mr.57.2.367-382.1993","article-title":"Roles of calcium ions in hyphal tip growth","volume":"57","author":"Jackson","year":"1993","journal-title":"Microbiol. Rev."},{"key":"2025030706145881500_r19","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/iai.58.5.1476-1478.1990","article-title":"Use of DBA\/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis","volume":"58","author":"Hector","year":"1990","journal-title":"Infect. Immun."},{"key":"2025030706145881500_r20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1023\/A:1007078106280","article-title":"Sialic acids in fungi: a minireview","volume":"16","author":"Alviano","year":"1999","journal-title":"Glycoconj. J."},{"key":"2025030706145881500_r21","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1128\/IAI.01001-07","article-title":"Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma","volume":"75","author":"Casadevall","year":"2007","journal-title":"Infect. Immun."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/194\/9\/4387\/61564631\/1401940.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/194\/9\/4387\/61564631\/1401940.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:19:30Z","timestamp":1741331970000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/194\/9\/4387\/7973053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,1]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,5,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1401940","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,5]]},"published":{"date-parts":[[2015,5,1]]}}}